RT Journal Article
SR Electronic
T1 The Dangers of Acute Kidney Injury in COVID-19 Patients: A Meta-Analysis of First Reports
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.29.20079038
DO 10.1101/2020.04.29.20079038
A1 Zhixiang Mou
A1 Xu Zhang
YR 2020
UL http://medrxiv.org/content/early/2020/05/14/2020.04.29.20079038.abstract
AB Purpose The coronavirus strain first reported in December 2019 (COVID-19) has spread rapidly worldwide, posing a seriously risk to human health. However, the relationship between acute kidney injury (AKI) and the COVID-19 infection is limited. There is ongoing controversy about AKI in COVID-19, some studies have argued the presence of AKI as being very common and a characteristic side-effect of the virus, while others pointed that AKI remains a rare incident among COVID-19 infections. This meta-analysis aims to shed much-needed light on the relationship between COVID-19 and AKI, and provide a stronger evidence base to support both further research and clinical application.Methods Two authors independently performed a literature search using PubMed, Web of Science, Embase, and Cochrane Library. Literature published up until May 04, 2020 (inclusive). Then the incidence of AKI, incidence of RRT required, the mortality rate with AKI and the risk of death with AKI during a COVID-19 infection were statistically analyzed using Open Meta-Analyst software, from which conclusions are derived.Results We found that the incidence of AKI in hospitalized patients with the COVID-19 infection remains low, only about 3.8%; the in-hospital mortality rate with AKI in COVID-19 infected patients reaches up to 86.8%; the odds of death with AKI in COVID-19 infected patients is about 24.2 times higher than those without AKI.Conclusions The occurrence of AKI during a COVID-19 infection should be paid greater attention, and should be considered a strong red flag with regards to the patient’s risk of death. Additional studies are still required to support the conclusions derived herein and to explore the AKI mechanism during a COVID-19 infection.Take-home message This meta-analysis was based on the inclusion of 5,448 in-hospital COVID-19 infected patients, and first time indicated that although the incidence of AKI observed during a COVID-19 infection is lower, but it is a strong signal of patient deterioration, to critical illness and even death.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this article.